JAGX

1.19

11.85% -0.16

Dopo l'orario di chiusura: 1.26 0.07 +5.88%

Jaguar Health Inc (JAGX)

Panoramica Notizia Cronologia dei prezzi Financials Perché JAGX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.35

Aprire:

$1.4

Volume 24 ore:

282.40K

Relative Volume:

1.35

Capitalizzazione di mercato:

$4.45M

Reddito:

$10.48M

Utile/perdita netta:

$-37.74M

Rapporto P/E:

-0.0735

EPS:

-16.1846

Flusso di cassa netto:

$-29.03M

1 W Prestazione:

+8.18%

1M Prestazione:

-33.15%

6M Prestazione:

-65.90%

1 anno Prestazione:

-95.09%

Intervallo 1D:

$1.16

$1.43

Intervallo di 1 settimana:

$1.05

$1.50

Portata 52W:

$1.00

$33.25

Jaguar Health Inc Stock (JAGX) Company Profile

Nome

Jaguar Health Inc

Settore

Healthcare (1131)

Industria

Biotechnology (631)

Telefono

415-371-8300

Indirizzo

200 PINE STREET SUITE 400, SAN FRANCISCO, CA

Dipendente

Cinguettio

@Jaguar_Health

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

JAGX's Discussions on Twitter

Confronta JAGX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
JAGX Jaguar Health Inc	1.19	5.04M	10.48M	-37.74M	-29.03M	-16.18
VRTX Vertex Pharmaceuticals Inc	455.71	114.69B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	752.62	77.91B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	850.95	54.05B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	391.50	52.52B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	196.92	42.02B	447.02M	-1.18B	-906.14M	-6.1812

Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-07-07	Iniziato	Cantor Fitzgerald	Overweight
2017-07-11	Iniziato	Rodman & Renshaw	Buy

Jaguar Health Inc Borsa (JAGX) Ultime notizie

03:35 AM

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF) - Central New Jersey News

03:35 AM

10:12 AM

Jaguar Health submits abstract on crofelemer for short bowel syndrome By Investing.com - Investing.com Canada

10:12 AM

09:56 AM

Jaguar Health (JAGX) Advances Treatment for Short Bowel Syndrome - GuruFocus

09:56 AM

09:54 AM

Jaguar Health submits abstract on crofelemer for short bowel syndrome - Investing.com

09:54 AM

09:00 AM

Jaguar Health (NASDAQ: JAGX) advances crofelemer program in SBS-IF, MVID trials - Stock Titan

09:00 AM

Dec 12, 2025

Jaguar Health Executes Strategic Stock Exchange Agreements - TipRanks

Dec 12, 2025

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs - The Florida Times-Union

Dec 12, 2025

Dec 11, 2025